The CMS Innovation Center is seeking feedback on the Medicare $2 Drug List (M2DL) voluntary model that would test whether standardized cost sharing for low-cost generics can improve medication adherence and health outcomes along with Medicare beneficiaries' and prescribers' satisfaction with the Part D program.
The model is designed...
Following last year’s controversial price transparency rule mandating that hospitals disclose the rates they negotiate with insurers online for specific services, payers have decided to counter the rule with an initiative of their own.
The Centers for Medicare and Medicaid Services (CMS) revealed the list of 70 mandated services...
